A Look Back at 2 Successful Biotech Buyouts


The biotech pharmaceutical business is all about clinical trials, FDA approvals and the potential market its addresses. Most of the biotech companies experienced rising stock market prices despite the fact that it had consistently generated negative earnings over time.



from Biotech News